Search bioRxiv⌕ Search

bioRxiv · 10.1101/2023.02.07.527589

Separation of function mutations in microcephaly protein CPAP/CENPJ, reveal its role in regulating centriole number and length.

Abstract

Centriole are microtubule-based cylindrical structures characterized by their definite size, and stable, slow growing microtubules. The centriole core protein CPAP/CENPJ is known to act as a molecular cap regulating centriole length by interacting with microtubule/tubulin via the conserved microtubule destabilizing, PN2-3, and microtubule stabilizing, A5N, domains. The C-terminus of CPAP has a conserved glycine-rich G-box/TCP domain (1050-1338 amino acids). This region is involved in centriole cartwheel assembly by interacting with the cartwheel protein STIL. However, previously reported primary microcephaly mutation mapped in the G-box of CPAP, i.e., E1235V (MCPH6) affects centriole length via an unknown mechanism. Recently, another primary microcephaly mutation has been mapped to this region of CPAP, i.e., D1196N. However, the effect of D1196N on CPAP functioning is not known. We simultaneously characterized these two MCPH mutations in the G-box of CPAP. We identified that despite affecting the same domain of CPAP, they affect distinct CPAP functions at the centriole. The E1235V mutation caused an overly long centriole, and the D1196N mutation increased the centriole number. Interestingly, both these mutations affect CPAP direct interaction with the cartwheel protein STIL, which is involved in CPAP recruitment to the centriole. Accordingly, the CPAP E1235V centriole localization is significantly affected at the centriole. However, CPAP D1196N can still localize to centriole at levels comparable to the wild-type CPAP. We show that CPAP utilizes an alternate CEP152-dependent route for centriole recruitment. Importantly, our work highlights the importance of the CPAP region outside direct microtubule/tubulin interacting domains in influencing CPAP activity in cartwheel assembly and centriole length. Perhaps, this is why deleterious naturally occurring missense mutations are frequently occurring in this particular region of CPAP in primary microcephaly.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Jaiswal, S., Sanghi, S., Singh, P.. 2023-02-08. Separation of function mutations in microcephaly protein CPAP/CENPJ, reveal its role in regulating centriole number and length.. https://doi.org/10.1101/2023.02.07.527589

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Sequence context and partner availability specify divergent cell fates from a single transcription factor

Transcription factors drive the gene regulatory networks that control developmental transitions, yet which of their many targets a cell uses remains unresolved. Expressing Cebp, Cebp{beta} or Cebp{delta} identically, alone or with Oct4, Sox2, Klf4 and cMyc, gave four outcomes: adipocyte from fibroblasts and neural stem cells, trophectoderm from embryonic stem cells, and myeloid from B cells. Raising Cebp levels changed how many sites it reached, not which sequence it read: clustered motifs maintained somatic enhancers, while spillover onto low-copy sites created de novo enhancers carrying composites of Cebp and cell-type-restricted partners. In fibroblasts, Cebp also redistributed Oct4, Sox2 and Klf4 from early targets, blocking iPSC formation. Supplying the predicted partners rewrote the output: Spi1 redirected Cebp into parallel adipogenic and myeloid programs, via a transient PpargCD45 state using separate enhancers for each; TFAP2C abolished adipogenic conversion. Motif density and partner composites therefore assemble a factor's instructive output in the receiving cell.

cell biology↗

Tracking the conformational dynamics of single molecules in live cells; GTPase cycling in Cdc42 gradients and microclusters

The Rho family of GTPases play a critical role in many cellular processes by acting as molecular switches relying on conformational changes to transition between active and inactive states. The spatial distribution and kinetics of these conformational changes are complex and vary across the cell. We describe here biosensors based on environment-responsive fluorescent dyes, capable of reporting the conformational changes of individual GTPase molecules as they traffic within living cells (SPARC Cdc42 and SPARC Rac1, 'Single Particle Activation Reporter Constructs'). We use SPARC Cdc42 to determine the rates of different steps in GTPase regulation, activation/inactivation and membrane insertion, that together generate localized gradients of Cdc42 activity driving cell motility. The biosensors also revealed heterogeneously distributed clusters of Cdc42, the mechanisms of their activation, and potential roles in polarized motility.

cell biology↗

High-content screening identifies FDA-approved activators of mitophagy

Mitochondrial diseases are highly heterogeneous disorders caused by defects in oxidative phosphorylation, for which only limited therapeutic options are available. The elimination of dysfunctional mitochondria via mitophagy activation is an attractive strategy to treat several mitochondrial diseases, irrespective of the underlying genetic defect. To identify pharmacological activators of this pathway, we performed a high-content screening of 1,971 FDA-approved compounds using cellular reporters of TFEB nuclear translocation and mitophagy. This screening identified 294 compounds that promoted TFEB translocation, nine of which increased the number of mitolysosomes without compromising cell viability or damaging mitochondria. Among the selected compounds, Meptazinol and Ponatinib emerged as the top-ranked mitophagy inducers in fibroblasts from patients with complex I and IV deficiency, respectively, and were prioritised for further characterisation. However, they did not rescue the bioenergetic defect, suggesting that the stimulation of mitophagy per se is not sufficient to ameliorate the OXPHOS defect in mitochondrial diseases. Overall, our findings establish a scalable platform for the identification of pharmacological activators of TFEB and identify candidate compounds for therapeutic modulation of mitophagy.

cell biology↗